Neonc Technologies Holdings Inc (NTHI)

$12.00 -0.11 (-0.91%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 9,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary b...

Industry: Biotechnology
Sector: Healthcare
Phone: 310-663-7831
Address:
23975 Park Sorrento, Suite 205, Calabasas, United States
Breqqswings
Breqqswings Jun. 26 at 4:02 PM
$NTHI broke above $4 I’m in
0 · Reply
PenkeTrading
PenkeTrading Jun. 19 at 9:08 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of NeOnc Technologies Holdings, Inc. Common Stock. Is that bullish or bearish? $NTHI #NeOnc #RsiOversold #NASDAQ
0 · Reply
TheCatalystCalendar
TheCatalystCalendar Jun. 18 at 7:55 PM
$NTHI HIGH RISK but here’s the idea: All the tickers that have run who had Dominari as a bookrunner this week ALSO have special financing deals with Mast Hill who has a reputation and noted strategy of selling shares to the open market as quickly as possible after getting the shares for financing. Those tickers have been $RELI, $SDOT, $LSE so far. It’s an absolutely shady situation that the SEC should try to stop but in the meantime us noticing it is not sketchy or illegal. It’s just a lot of reading 😂. So we are piggy backing on the other ticker that had Dominari as a bookrunner and has a deal with Mast Hill: $NTHI
2 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 9 at 9:35 AM
WATCHLIST JUN 09 2025 $NTHI NeOnc Technologies Says USC Brain Tumor Authority To Accelerate Four Clinical Trials Including Lead Asset NEO100 Nearing Phase 2a Completion Ahead Of Schedule $DOCU B of A Securities Maintains Neutral on Docusign, Lowers Price Target to $85 $ADVB Advanced Biomed Enters Purchase Agreement With Helena Global; To Issue And Sell Up To $25M In Common Stock $CLVT Clarivate Deepens Longstanding Partnership With American Library Association By Supporting Public Advocacy Through 2027 $HBAN Argent Institutional Trust Company Agrees To Acquire Corporate Trust And Institutional Custody Business Of Huntington National Bank; Terms Not Disclosed
0 · Reply
MicsMugz
MicsMugz May. 27 at 1:48 AM
My list for tommorrow. $ZEOX $NTHI $TBRG $GROV $UAVS
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 20 at 3:30 AM
$NTHI CEO purchased 400 shares at $7.00 for a total of $2,800. CHEN THOMAS C now owns 4,582,349 shares. https://ceo-buys.com
0 · Reply
Armonica423
Armonica423 May. 10 at 8:33 PM
$NTHI Big exposure for CYDY at 3 oncology conferences this week, do your dd research
0 · Reply
_www_larval_com_
_www_larval_com_ May. 8 at 7:53 PM
$VEEE -7%[186%] $WBUY -6%[129%] $NTHI -6%[17%] $RYET 4%[29%] $HTCO 4%[25%] most notable movement into the final minutes of trading.
0 · Reply
FrancisDoam
FrancisDoam May. 8 at 10:24 AM
$BODI $NTHI $EYE $APPS $ATRO
0 · Reply
Spiderman1979
Spiderman1979 Apr. 24 at 5:07 PM
$NTHI anyone here? Lol
0 · Reply
Latest News on NTHI
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

Jun 6, 2025, 9:00 AM EDT - 20 days ago

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

Apr 15, 2025, 8:05 AM EDT - 2 months ago

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

Apr 14, 2025, 8:05 AM EDT - 2 months ago

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

Apr 10, 2025, 8:05 AM EDT - 2 months ago

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

Apr 8, 2025, 4:05 PM EDT - 2 months ago

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

Mar 31, 2025, 8:05 AM EDT - 3 months ago

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

Mar 27, 2025, 8:05 AM EDT - 3 months ago

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

Mar 25, 2025, 8:45 AM EDT - 3 months ago

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

Mar 25, 2025, 8:15 AM EDT - 3 months ago

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

Jan 4, 2025, 12:30 AM EST - 6 months ago

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

AERO CAPS CRGT FBGL FLOC INLF INR

NeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024

Oct 7, 2024, 11:00 AM EDT - 9 months ago

NeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

Aug 5, 2024, 11:00 AM EDT - 11 months ago

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation

Jul 16, 2024, 11:15 AM EDT - 1 year ago

NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

Jun 26, 2024, 4:39 PM EDT - 1 year ago

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

NeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement Award

May 15, 2024, 11:00 AM EDT - 1 year ago

NeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement Award

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

May 9, 2024, 5:30 PM EDT - 1 year ago

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

Mar 30, 2024, 1:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

BOLD MMA MNDR NTCL ROTR UBXG WAY

U.S. IPO Weekly Recap: Small Japanese Lists In The US As Insurer Aspen Holdings Joins The IPO Pipeline

Dec 25, 2023, 9:05 AM EST - 1 year ago

U.S. IPO Weekly Recap: Small Japanese Lists In The US As Insurer Aspen Holdings Joins The IPO Pipeline

LGCB MAMO LZMH

Neonc Technologies Seeks U.S. IPO For Brain Cancer Treatment Pipeline

Dec 20, 2023, 2:38 PM EST - 1 year ago

Neonc Technologies Seeks U.S. IPO For Brain Cancer Treatment Pipeline

Breqqswings
Breqqswings Jun. 26 at 4:02 PM
$NTHI broke above $4 I’m in
0 · Reply
PenkeTrading
PenkeTrading Jun. 19 at 9:08 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of NeOnc Technologies Holdings, Inc. Common Stock. Is that bullish or bearish? $NTHI #NeOnc #RsiOversold #NASDAQ
0 · Reply
TheCatalystCalendar
TheCatalystCalendar Jun. 18 at 7:55 PM
$NTHI HIGH RISK but here’s the idea: All the tickers that have run who had Dominari as a bookrunner this week ALSO have special financing deals with Mast Hill who has a reputation and noted strategy of selling shares to the open market as quickly as possible after getting the shares for financing. Those tickers have been $RELI, $SDOT, $LSE so far. It’s an absolutely shady situation that the SEC should try to stop but in the meantime us noticing it is not sketchy or illegal. It’s just a lot of reading 😂. So we are piggy backing on the other ticker that had Dominari as a bookrunner and has a deal with Mast Hill: $NTHI
2 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 9 at 9:35 AM
WATCHLIST JUN 09 2025 $NTHI NeOnc Technologies Says USC Brain Tumor Authority To Accelerate Four Clinical Trials Including Lead Asset NEO100 Nearing Phase 2a Completion Ahead Of Schedule $DOCU B of A Securities Maintains Neutral on Docusign, Lowers Price Target to $85 $ADVB Advanced Biomed Enters Purchase Agreement With Helena Global; To Issue And Sell Up To $25M In Common Stock $CLVT Clarivate Deepens Longstanding Partnership With American Library Association By Supporting Public Advocacy Through 2027 $HBAN Argent Institutional Trust Company Agrees To Acquire Corporate Trust And Institutional Custody Business Of Huntington National Bank; Terms Not Disclosed
0 · Reply
MicsMugz
MicsMugz May. 27 at 1:48 AM
My list for tommorrow. $ZEOX $NTHI $TBRG $GROV $UAVS
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 20 at 3:30 AM
$NTHI CEO purchased 400 shares at $7.00 for a total of $2,800. CHEN THOMAS C now owns 4,582,349 shares. https://ceo-buys.com
0 · Reply
Armonica423
Armonica423 May. 10 at 8:33 PM
$NTHI Big exposure for CYDY at 3 oncology conferences this week, do your dd research
0 · Reply
_www_larval_com_
_www_larval_com_ May. 8 at 7:53 PM
$VEEE -7%[186%] $WBUY -6%[129%] $NTHI -6%[17%] $RYET 4%[29%] $HTCO 4%[25%] most notable movement into the final minutes of trading.
0 · Reply
FrancisDoam
FrancisDoam May. 8 at 10:24 AM
$BODI $NTHI $EYE $APPS $ATRO
0 · Reply
Spiderman1979
Spiderman1979 Apr. 24 at 5:07 PM
$NTHI anyone here? Lol
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 9 at 12:34 PM
$NTHI (+10.1% pre) NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy https://ooc.bz/l/61270
0 · Reply
beppels
beppels Apr. 9 at 12:19 PM
$DXF $FATN $SLSN $NTHI 4 out of 4 hitting!:)
0 · Reply
briefingcom
briefingcom Apr. 9 at 12:18 PM
Gapping up: $VERO +287% $DXF +65.1% $NTHI +15.2% $BTU +10.4%
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Apr. 9 at 10:12 AM
WATCHLIST APR 09 2025. $RXRX Recursion Announces First Patient Dosed In Phase 1 Clinical Study Of REC-3565 For Relapsed Or Refractory B-cell Lymphomas $AIRJ AirJoule Technologies Partners With Arizona State University To Supply High-Capacity AirJoule A250TM System For Water Harvesting Research, Demonstrating Over 4x Efficiency Compared To Traditional Moisture Removal Systems $CVRX Lake Street Maintains Buy on CVRx, Lowers Price Target to $14 $NTHI NeOnc Technologies shares are trading higher after the company announced near full enrollment for its Phase 1 clinical trial of NEO212 for brain cancer $ANNX Annexon Says Tanruprubart Met The Primary Endpoint; Demonstrates Rapid, Durable Recovery and Superior Efficacy In First Placebo-Controlled Phase 3 GBS Trial, Showing Significant Improvement In Motor Function, Mobility, and Disability Measures Over Placebo With No New Safety Signals
0 · Reply
beppels
beppels Apr. 9 at 5:29 AM
$DXF BEPPELS WL 09.04.: - $DXF, 220 K float, lowest on nasdaq, ah runner, known for crazy spikes, just 7 k to borrow! ✅ - $FATN, ipo yesterday, 696 k float, HoD was 24, came down to 9 in ah! ✅ - $SLSN, 18 mln float, uplister to nasdaq, hit 16.5 HoD, came down to 1.7! ✅ - $NTHI, 2.2 mln float, good news in ah plus promo today! ✅ Low floaters are the hot theme! 👀 🔥 👀
0 · Reply
PipGladiator_33
PipGladiator_33 Apr. 8 at 1:31 PM
$NTHI every red candle is just another chance to flex when Nissan headlines hit 📉💪
0 · Reply
Fib7867
Fib7867 Apr. 7 at 10:48 PM
#myNTHIanalysis $NTHI
0 · Reply
rosales_trade
rosales_trade Apr. 7 at 2:03 PM
🚨 Is this March 2020, round two? Nikkei -7.9%, Hang Seng down 13% - worst day since 1997 😱 $AEHL, $NTHI — also in the red. Trump's latest tariffs hit like a hammer. What’s everyone buying on the dip? Feels like we’re at the bottom. Looking for advice from experienced traders 🐺📉
0 · Reply
theshortsqueezer2022
theshortsqueezer2022 Apr. 6 at 9:49 PM
$NTHI trades like a 10K float. Reminds me of $HKD
0 · Reply
KeLee98
KeLee98 Apr. 4 at 7:21 PM
In today's market downturn, savvy investors recognize that opportunities often arise when stocks are undervalued. Nuvve stands out as a compelling investment during these times.​ Nuvve’s Q4 and full-year 2024 results show positive progress: ✅ Growing Revenue: $1.79M, up from $1.64M last year ✅ Lower Costs: Operating expenses down 67%; net loss reduced by 80% ✅ Growth: Megawatts under management up 16% ✅ Key Milestones: First V2G-capable school bus in New Mexico, new AC V2G tech unveiled, and EV charging partnership with WISE EV $NTHI
0 · Reply
HaltTradeAlert
HaltTradeAlert Apr. 4 at 7:13 PM
$NTHI Halt Time: 15:11:49 Issue Symbol: NTHI Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
HaltTradeAlert
HaltTradeAlert Apr. 4 at 7:08 PM
$NTHI Halt Time: 15:06:15 Issue Symbol: NTHI Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply